Pure speculation on my part sure but here is the following factual timeline:
The case has drug on for four and a half years and they are barely past the Markman phase. She delayed the Markman hearing for months for the Whitey case and then took eight months to publish the Markman opinion. The case was then stayed pending the results of the IPR proceedings.
In my experience, most judges except those in East/North Texas, some in NDCA, a few in NJ, and four or so in Delaware would rather not hear patent cases. This is my biggest gripe when venue reform is brought up. If they are going to distribute the cases evenly across the US instead of the current concentrated system we currently have, they need to figure out a way to find judges who have experience in patent law and actually want to take on the cases.
News 
Market Data 
Discover 
